WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • 1 - 5 Users Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Global Cardiac Assist Device Market 2011-2015

Infiniti Research Limited, May 2012, Pages: 38

TechNavio’s analysts forecast the Global Cardiac Assist Device market to grow at a CAGR of 8.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular diseases (CVDs). The Global Cardiac Assist Device market has also been witnessing the trend of paradigm shift toward total artificial heart (TAH). However, the low adoption rate of CAD in developing countries could pose a challenge to the growth of this market.

TechNavio’s report, the Global Cardiac Assist Device Market 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Thoratec Corp., Maquet Getinge Group, Abiomed Inc., HeartWare International Inc.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Thoratec Corp.
15.2 Maquet GmbH & Co. KG
15.3 Abiomed Inc.
15.4 HeartWare International Inc.
16. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Cardiac Assist Device Market 2011–2015 (US$ million)
Exhibit 2: Sub-segmentation of Cardiac Assist Devices
Exhibit 3: Global Cardiac Assist Device Market by Product Segmentation 2011
Exhibit 4: Global Cardiac Assist Device Market by Geographical Segmentation 2011
Exhibit 5: Global Cardiac Assist Device Market by Vendor Segmentation 2011

TechNavio Announces the Publication of its Report – Global Cardiac Assist Device Market 2011–2015
TechNavio today launched its report Global Cardiac Assist Device Market 2011–2015 based on an in-depth study covering the Americas and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.

Commenting on the report, an analyst from TechNavio’s Healthcare team said; “The Global Cardiac Assist Device (CAD) market is witnessing various technological advancements that have increased the demand for and adoption of CADs among physicians and cardiologists. Cardiologists prefer total artificial hearts (TAHs) to ventricular assist devices (VADs) for the treatment of patients who are waiting for heart transplants (destination therapy). Since the introduction of the TAH, there have been huge implantations of the device.”

According to the report, worldwide, there is increasing prevalence of cardiovascular diseases (CVDs). Furthermore, the rapid increase in the aging population across the globe has increased the number of people suffering from congestive heart failure (CHF). In the US, huge numbers of people are living with CHF, and numerous new cases of heart failure are diagnosed every year. However, the survival rate of these patients has greatly improved in the US since the introduction of CADs. Thus, the high prevalence of CVDs has increased the demand for CADs.

Further, the report also discusses that the high cost of CAD procedures is a major factor restricting the adoption of CADs in developing regions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.

Thoratec, Maquet Getinge, Abiomed, HeartWare International

Customers who bought this item also bought